Dihydromyricetin Ameliorates Cardiac Ischemia/Reperfusion Injury through Sirt3 Activation
DHM improved cardiac function after MI/R. (a, b) LVEF, LVFS was measured by echocardiography. (c, d) The maximal ± LV dp / dt was obtained by hemodynamic evaluation. Mean ± SEM (n=12), P<0.05 vs WT+sham group; #P<0.05 vs Sirt3−/− + sham group; §P < 0.05 vs MI/R group; P<0.05 vs Sirt3−/−+MI/R group; &P<0.05 vs MI/R +DHM group.
Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.